Clinical Efficacy of Deep Transcranial Magnetic Stimulation in Psychiatric and Cognitive Disorders: Protocol for a Systematic Review
Open accessPublished version of a preprint
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Background: Transcranial magnetic stimulation (TMS) is a widely used noninvasive brain stimulation technique for psychiatric and cognitive disorders. In recent years, deep TMS (dTMS) has shown promise as an enhanced form of TMS able to stimulate deeper brain structures and target broader networks. Various magnetic Hesed-coil (H-coil) designs—a novel feature of dTMS—have been used to stimulate brain regions implicated in the pathophysiology of specific psychiatric and cognitive disorders, thereby producing therapeutic effects. Given the novelty of dTMS in psychiatry, little is known about the clinical efficacy of dTMS across psychiatric and cognitive disorders—that is, whether dTMS performs superiorly to sham or control. Objective: In this paper, we outline a protocol for a systematic review investigating the clinical efficacy of dTMS. The primary objective is to conduct a systematic review of the literature on dTMS for psychiatric and cognitive disorders and, if feasible, a meta-analysis to compare the efficacy of active dTMS versus sham/control for psychiatric disorders. Dementia and related cognitive disorders will also be examined. A secondary objective will be to examine subgroup differences (by age, sex, H-coil design, and dTMS parameters [ie, pulses per session, percentage of motor threshold, etc]) to evaluate whether dTMS differentially influences clinical outcomes based on these factors. Methods: A comprehensive search of the APA PsycINFO, Embase, MEDLINE, and PubMed databases will be conducted using keywords such as “H-coil” and “dTMS.” Two authors (AD and MD) will be responsible for screening relevant articles, assessing article eligibility (according to predetermined inclusion and exclusion criteria), and data extraction. All included articles will undergo a quality and risk of bias assessment. Data from included articles will be summarized qualitatively in a systematic review. If a sufficient number of equivalent studies are available, a meta-analysis will be performed to (1) determine the effect of active versus sham dTMS (or another control arm) across psychiatric and cognitive disorders, and (2) examine subgroup effects of clinical outcomes. Results: The preliminary search rendered a total of 1134 articles from the APA PsycINFO, Embase, and MEDLINE databases. After full-text screening, 21 eligible articles remained. One additional article was identified from the references section of an existing systematic review. In total, 22 eligible articles were included. Data extraction and quality of assessment procedures are ongoing. Conclusions: We will outline the evidence relating to the clinical efficacy of dTMS in various psychiatric and cognitive disorders. The results of the prospective systematic review will provide clinicians with valuable insight into the clinical (ie, participant age, sex, psychiatric or cognitive disorder, etc) and methodological factors (ie, H-coil design, dTMS parameters, etc) which may contribute to dTMS efficacy, and thereby may assist clinicians in their decision to prescribe dTMS for specific psychiatric and cognitive disorders. Trial Registration: PROSPERO CRD42022360066; https://tinyurl.com/5ev6byrn International Registered Report Identifier (IRRID): DERR1-10.2196/45213
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Deep TMS (dTMS), utilizes H-coils to extend this stimulation to deeper targets, while also offering more favorable safety and tolerability profiles [6,100,101,102,103,104,105].”
From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It represents the strongest endogenous magnetic signal in the human body, up to 100 times stronger than the brain’s [5,6]”
From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It represents the strongest endogenous magnetic signal in the human body, up to 100 times stronger than the brain’s [5,6]”
From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“Articles will be screened in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [60] guidelines.”
MethodWang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 2×
“All articles will be assessed according to the grading of recommendations, assessment, development, and evaluations (GRADE) checklist [61,62] to evaluate the quality of data and risk of bias.”
MethodRush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688 · cited 1×
“Research on other therapy options, such as vagus nerve stimulation [33,34] and deep brain stimulation [35-37], have continued to accumulate, offering further insight into these treatment options for psychiatric disorders.”
Meader, N., King, K., Llewellyn, A., Norman, G., Brown, J., Rodgers, M., Moe-Byrne, T., Higgins, J. P., Sowden, A., & Stewart, G. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-82 · Cited by 610 · cited 2×
“All articles will be assessed according to the grading of recommendations, assessment, development, and evaluations (GRADE) checklist [61,62] to evaluate the quality of data and risk of bias.”
MethodZhdanava, M., Pilon, D., Ghelerter, I., Chow, W., Joshi, K., Lefebvre, P., & Sheehan, J. J. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13699 · Cited by 523 · cited 1×
“In particular, treatment resistance occurs in approximately one third of patients with major depressive disorder [9,10], 30%-60% of patients with schizophrenia [11-13], and 40%-60% of patients with obsessive-compulsive disorder [14,15].”
BackgroundTranscranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-Coil
Zangen, A., Roth, Y., Voller, B., & Hallett, M. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.11.008 · Cited by 473 · cited 2×
“While traditional TMS figure-8 coils generally stimulate subdural cortical targets up to 0.7 cm [44], dTMS target areas are up to 4 cm beneath the surface depending on the chosen H-coil [45].”
BackgroundInfluentialCarmi, L., Tendler, A., Bystritsky, A., Hollander, E., Blumberger, D. M., Daskalakis, J., Ward, H., Lapidus, K., Goodman, W., Casuto, L., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101180 · Cited by 458 · cited 1×
“…the findings of recent dTMS clinical trials in patients with various psychiatric and cognitive disorders, including Alzheimer disease [55], attention-deficit or hyperactivity disorder [56], obsessive-compulsive disorder [57], posttraumatic stress disorder [58], and substance use disorder [59].”
BackgroundSanford, A. M. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.02.005 · Cited by 436
Treatment resistance in psychiatry: state of the art and new directions
Howes, O. D., Thase, M. E., & Pillinger, T. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01200-3 · Cited by 413 · cited 1×
“[2] Of greater concern, it is estimated that 20%-60% of patients with psychiatric disorders are treatment-resistant to first-line medications [8].”
BackgroundPallanti, S., & Quercioli, L. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.028 · Cited by 408 · cited 1×
“In particular, treatment resistance occurs in approximately one third of patients with major depressive disorder [9,10], 30%-60% of patients with schizophrenia [11-13], and 40%-60% of patients with obsessive-compulsive disorder [14,15].”
BackgroundPell, G. S., Roth, Y., & Zangen, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.003 · Cited by 406 · cited 1×
“Trains of pulses can be delivered at high-frequency stimulation (>5 Hz) to increase neuronal excitability or at low-frequency stimulation (~1 Hz) to reduce neural excitability [42].”
BackgroundRoth, Y., Amir, A., Levkovitz, Y., & Zangen, A. (2007) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31802fa393 · Cited by 389 · cited 2×
“While traditional TMS figure-8 coils generally stimulate subdural cortical targets up to 0.7 cm [44], dTMS target areas are up to 4 cm beneath the surface depending on the chosen H-coil [45].”
BackgroundMethodInfluentialA Coil Design for Transcranial Magnetic Stimulation of Deep Brain Regions
Roth, Y., Zangen, A., & Hallett, M. (2002) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200208000-00008 · Cited by 326 · cited 1×
“Another promising method—known as deep TMS (dTMS)—is a noninvasive technique allowing for stimulation of deeper cortical areas and presumably deeper neural networks [38,39].”
MethodCoil design considerations for deep transcranial magnetic stimulation
Deng, Z.-D., Lisanby, S. H., & Peterchev, A. V. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.11.038 · Cited by 308 · cited 2×
“More than 20 different types of H-coils have been developed to effectively stimulate specific brain structures [46].”
BackgroundDandekar, M. P., Fenoy, A. J., Carvalho, A. F., Soares, J. C., & Quevedo, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2018.2 · Cited by 266
Isserles, M., Shalev, A. Y., Roth, Y., Peri, T., Kutz, I., Zlotnick, E., & Zangen, A. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.07.008 · Cited by 260 · cited 2×
“However, only 1 sham-controlled dTMS study [49] was included in this review.”
BackgroundA pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders
George, M. S., Ward, H. E., Ninan, P. T., Pollack, M., Nahas, Z., Anderson, B., Kose, S., Howland, R. H., Goodman, W. K., & Ballenger, J. C. (2008) · Brain Stimulation · doi:10.1016/j.brs.2008.02.001 · Cited by 251 · cited 1×
“Research on other therapy options, such as vagus nerve stimulation [33,34] and deep brain stimulation [35-37], have continued to accumulate, offering further insight into these treatment options for psychiatric disorders.”
BackgroundQuality of life of people with schizophrenia, bipolar disorder and other psychotic disorders
Saarni, S. I., Viertiö, S., Perälä, J., Koskinen, S., Lönnqvist, J., & Suvisaari, J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076489 · Cited by 251 · cited 1×
“Psychiatric [1,2] and cognitive disorders [3] are leading causes of disability and burden worldwide and are associated with substantially poorer quality of life [4-7].”
BackgroundCognitive Impairment: An Independent Predictor of Excess Mortality: A Cohort Study
Sachs, G. A., Carter, R., Holtz, L. R., Smith, F., Stump, T. E., Tu, W., & Callahan, C. M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-5-201109060-00007 · Cited by 189 · cited 1×
“Further, older adults with mild cognitive impairment show an increased risk of mortality [17,18].”
BackgroundQuality of life in patients with mild cognitive impairment
Bárrios, H., Narciso, S., Guerreiro, M., Maroco, J., Logsdon, R., & de Mendonça, A. (2013) · Aging & Mental Health · doi:10.1080/13607863.2012.747083 · Cited by 182
Chen, Y., Liang, N., Li, X., Yang, S.-H., Wang, Y., & Shi, N. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.719849 · Cited by 181
Transcranial magnetic stimulation for the treatment of major depression
Janicak, P. G., & Dokucu, M. E. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s67477 · Cited by 176 · cited 1×
“These noninvasive stimulation techniques offer potentially propitious therapy for neurological and psychiatric disorders [32].”
BackgroundCollaborators, G. 2. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12200 · Cited by 176
Lu, M., & Ueno, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178422 · Cited by 172 · cited 1×
“Another promising method—known as deep TMS (dTMS)—is a noninvasive technique allowing for stimulation of deeper cortical areas and presumably deeper neural networks [38,39].”
MethodTranscranial magnetic stimulation: A review of its evolution and current applications
Saini, R., Chail, A., Bhat, P., Srivastava, K., & Chauhan, V. (2018) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_88_18 · Cited by 170 · cited 1×
“Traditional single-pulse TMS is used to explore brain functioning, whereas repetitive TMS (rTMS) is administered to induce brain activity that lasts beyond the stimulation period [31].”
Deep Brain Stimulation for Depression Informed by Intracranial Recordings
Sheth, S. A., Bijanki, K. R., Metzger, B., Allawala, A., Pirtle, V., Adkinson, J. A., Myers, J., Mathura, R. K., Oswalt, D., Tsolaki, E., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.007 · Cited by 158 · cited 1×
“Research on other therapy options, such as vagus nerve stimulation [33,34] and deep brain stimulation [35-37], have continued to accumulate, offering further insight into these treatment options for psychiatric disorders.”
BackgroundTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
Lally, J., Gaughran, F., Timms, P. W., & Curran, S. R. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s115741 · Cited by 153
Samara, M. T., Nikolakopoulou, A., Salanti, G., & Leucht, S. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby095 · Cited by 144 · cited 1×
“In particular, treatment resistance occurs in approximately one third of patients with major depressive disorder [9,10], 30%-60% of patients with schizophrenia [11-13], and 40%-60% of patients with obsessive-compulsive disorder [14,15].”
BackgroundMagierski, R., Sobów, T., Schwertner, E., & Religa, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01168 · Cited by 144
Vagus nerve stimulation in psychiatry: a systematic review of the available evidence
Cimpianu, C.-L., Strube, W., Falkai, P., Palm, U., & Hasan, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1642-2 · Cited by 138 · cited 1×
“Brain stimulation methods have shown increasing promise and widespread acceptance as nonpharmacological interventions to treat various psychiatric [24,25] and cognitive disorders [26,27].”
BackgroundBerghöfer, A., Martin, L., Hense, S., Weinmann, S., & Roll, S. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02470-0 · Cited by 122
Harel, M., Perini, I., Kämpe, R., Alyagon, U., Shalev, H., Besser, I., Sommer, W. H., Heilig, M., & Zangen, A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.020 · Cited by 115 · cited 1×
“…the findings of recent dTMS clinical trials in patients with various psychiatric and cognitive disorders, including Alzheimer disease [55], attention-deficit or hyperactivity disorder [56], obsessive-compulsive disorder [57], posttraumatic stress disorder [58], and substance use disorder [59].”
BackgroundMar‐Barrutia, L., Real, E., Segalàs, C., Bertolín, S., Menchón, J. M., & Alonso, P. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i9.659 · Cited by 114 · cited 1×
“Research on other therapy options, such as vagus nerve stimulation [33,34] and deep brain stimulation [35-37], have continued to accumulate, offering further insight into these treatment options for psychiatric disorders.”
BackgroundTeselink, J., Bawa, K. K., Koo, G. K., Sankhe, K., Liu, C. S., Rapoport, M., Oh, P., Marzolini, S., Gallagher, D., Swardfager, W., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101499 · Cited by 111 · cited 1×
“Brain stimulation methods have shown increasing promise and widespread acceptance as nonpharmacological interventions to treat various psychiatric [24,25] and cognitive disorders [26,27].”
BackgroundIsserles, M., Tendler, A., Roth, Y., Bystritsky, A., Blumberger, D. M., Ward, H. E., Feifel, D., Viner, L., Duffy, W. J., Zohar, J., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.019 · Cited by 109 · cited 1×
“…the findings of recent dTMS clinical trials in patients with various psychiatric and cognitive disorders, including Alzheimer disease [55], attention-deficit or hyperactivity disorder [56], obsessive-compulsive disorder [57], posttraumatic stress disorder [58], and substance use disorder [59].”
BackgroundBloch, M. H., Green, C., Kichuk, S. A., Dombrowski, P. A., Wasylink, S., Billingslea, E., Landeros-Weisenberger, A., Kelmendi, B., Goodman, W. K., Leckman, J. F., et al. (2013) · Depression and Anxiety · doi:10.1002/da.22103 · Cited by 94 · cited 1×
“In particular, treatment resistance occurs in approximately one third of patients with major depressive disorder [9,10], 30%-60% of patients with schizophrenia [11-13], and 40%-60% of patients with obsessive-compulsive disorder [14,15].”
BackgroundLevkovitz, Y., Rabany, L., Harel, E. V., & Zangen, A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000642 · Cited by 87 · cited 1×
“Various H-coil designs have been shown to be safe and efficacious in the treatment of various neuropsychiatric conditions [47-49].”
BackgroundRoth, Y., Pell, G. S., Chistyakov, A. V., Sinai, A., Zangen, A., & Zaaroor, M. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.07.013 · Cited by 84 · cited 1×
“The use of a Hesed-coil (H-coil) dTMS system is a relatively novel noninvasive method that stimulates deeper regions of the brain in comparison to traditional rTMS [43,44].”
MethodElectroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes
Deng, Z., Árgyelán, M., Miller, J., Quinn, D. K., Lloyd, M., Jones, T. R., Upston, J., Erhardt, E. B., McClintock, S. M., & Abbott, C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01380-y · Cited by 80 · cited 1×
“Electroconvulsive therapy [28] and transcranial magnetic stimulation (TMS) [29,30] are the most commonly used treatments, which involve the stimulation of the brain through electrical currents and magnetic pulses, respectively.”
BackgroundLorentzen, R., Nguyen, T. D., Mcgirr, A., Hieronymus, F., & Østergaard, S. (2021) · Schizophrenia · doi:10.1038/s41537-022-00248-6 · Cited by 80 · cited 1×
“Electroconvulsive therapy [28] and transcranial magnetic stimulation (TMS) [29,30] are the most commonly used treatments, which involve the stimulation of the brain through electrical currents and magnetic pulses, respectively.”
BackgroundSigrist, C., Vöckel, J., MacMaster, F. P., Farzan, F., Croarkin, P. E., Galletly, C. A., Kaess, M., Bender, S., & Koenig, J. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-02021-7 · Cited by 73 · cited 1×
“Electroconvulsive therapy [28] and transcranial magnetic stimulation (TMS) [29,30] are the most commonly used treatments, which involve the stimulation of the brain through electrical currents and magnetic pulses, respectively.”
BackgroundAntunes, A., Frasquilho, D., Azeredo-Lopes, S., Neto, D., Silva, M., Cardoso, G., & Caldas-de-Almeida, J. M. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.12.004 · Cited by 66
Impact of Mild Cognitive Impairment on Mortality and Cause of Death in the Elderly
Bae, J. B., Han, J. W., Kwak, K. P., Kim, B., Kim, S. G., Kim, J. L., Kim, T. H., Ryu, S., Moon, S. W., Park, J. H., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171182 · Cited by 66 · cited 1×
“Further, older adults with mild cognitive impairment show an increased risk of mortality [17,18].”
BackgroundRepetitive transcranial magnetic stimulation in psychiatry
Praharaj, S. K., Mishra, B., Sarkar, S., Mehta, V. S., Diwedi, S., & Nizamie, S. (2011) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.91935 · Cited by 60 · cited 1×
“Brain stimulation methods have shown increasing promise and widespread acceptance as nonpharmacological interventions to treat various psychiatric [24,25] and cognitive disorders [26,27].”
BackgroundPharmacological management of behavioral symptoms associated with dementia
Madhusoodanan, S., & Ting, M. B. (2014) · World Journal of Psychiatry · doi:10.5498/wjp.v4.i4.72 · Cited by 58 · cited 1×
“Currently, there are no effective treatment options to delay the progression of mild cognitive impairment and dementia [19], nor are there effective interventions to manage the behavioral and psychological burdens of such conditions [20-23].”
BackgroundDisease Burdens of Alzheimer's Disease, Vascular Dementia, and Mild Cognitive Impairment
Moon, W., Han, J. W., Bae, J. B., Suh, S. W., Kim, T. H., Kwak, K. P., Kim, B., Kim, S. G., Kim, J. L., Moon, S. W., et al. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.05.040 · Cited by 51 · cited 1×
“Psychiatric [1,2] and cognitive disorders [3] are leading causes of disability and burden worldwide and are associated with substantially poorer quality of life [4-7].”
BackgroundDeep TMS in a resistant major depressive disorder: a brief report
Rosenberg, O., Shoenfeld, N., Zangen, A., Kotler, M., & Dannon, P. N. (2010) · Depression and Anxiety · doi:10.1002/da.20689 · Cited by 50
Zhang, X., Lan, X., Chen, C., Ren, H., & Guo, Y. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.723715 · Cited by 47 · cited 1×
“Brain stimulation methods have shown increasing promise and widespread acceptance as nonpharmacological interventions to treat various psychiatric [24,25] and cognitive disorders [26,27].”
BackgroundDarbyshire, P., & Darbyshire, A. (2010) · Getting StartED with Google Apps · doi:10.1007/978-1-4302-2666-6_6 · Cited by 46
Bleich‐Cohen, M., Gurevitch, G., Carmi, N., Medvedovsky, M., Bregman, N., Nevler, N., Elman, K., Ginou, A., Zangen, A., & Ash, E. L. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102670 · Cited by 45 · cited 1×
“…the findings of recent dTMS clinical trials in patients with various psychiatric and cognitive disorders, including Alzheimer disease [55], attention-deficit or hyperactivity disorder [56], obsessive-compulsive disorder [57], posttraumatic stress disorder [58], and substance use disorder [59].”
BackgroundPrevalence of treatment-resistant psychoses in the community: A naturalistic study
Beck, K., McCutcheon, R. A., Stephenson, L., Schilderman, M., Patel, N., Ramsay, R., & Howes, O. D. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855995 · Cited by 43
Fadini, T., Matthäus, L., Rothkegel, H., Sommer, M., Tergau, F., Schweikard, A., Paulus, W., & Nitsche, M. A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.02.176 · Cited by 42 · cited 2×
“Brief magnetic pulses cause widespread neural depolarization in deep regions of the brain, resulting in reduced focal distribution of the electric field [41].”
BackgroundMethodDeep TMS H7 Coil: Features, Applications & Future
Harmelech, T., Roth, Y., & Tendler, A. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.2013803 · Cited by 36
Hung, Y.-Y., Yang, L.-H., Stubbs, B., Li, D.-J., Tseng, P.-T., Yeh, T.-C., Chen, T.-Y., Liang, C.-S., & Chu, C.-S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109850 · Cited by 33 · cited 2×
“Given the increasing interest in the application of dTMS in psychiatry [52], it is critical that its clinical effects are systematically appraised.”
BackgroundLeocani, L., Costa, G. D., Coppi, E., Santangelo, R., Pisa, M., Ferrari, L., Bernasconi, M. P., Falautano, M., Zangen, A., Magnani, G., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.614351 · Cited by 33 · cited 1×
“…to synthesize the findings of recent dTMS clinical trials in patients with various psychiatric and cognitive disorders, including Alzheimer disease [55], attention-deficit or hyperactivity disorder [56], obsessive-compulsive disorder [57], posttraumatic stress disorder [58], and substance use…”
BackgroundMcGirr, A., Devoe, D. J. A., Raedler, A., Debert, C. T., Ismail, Z., & Berlim, M. T. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720982432 · Cited by 30 · cited 1×
“One systematic review [53] explored the effects of rTMS in patients with posttraumatic stress disorder.”
BackgroundKedzior, K. K., Gerkensmeier, I., & Schuchinsky, M. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1704-0 · Cited by 25 · cited 1×
“Another systematic review [54] examined the effects of dTMS for substance use disorders; however, clinical efficacy was not appraised due to the limited number of sham-controlled trials.”
BackgroundQuality of Life across Mental Disorders in Psychiatric Outpatients
Sagayadevan, V., Lee, S. P., Ong, C. W., Abdin, E., Chong, S. A., & Subramaniam, M. (2018) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v47n7p243 · Cited by 24 · cited 1×
“Psychiatric [1,2] and cognitive disorders [3] are leading causes of disability and burden worldwide and are associated with substantially poorer quality of life [4-7].”
BackgroundHow to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression
Tendler, A., Roth, Y., Barnea‐Ygael, N., & Zangen, A. (2017) · Journal of Visualized Experiments · doi:10.3791/55100 · Cited by 22 · cited 1×
“The H1-coil was designed to stimulate the bilateral prefrontal cortex with preference to the left dorsolateral prefrontal cortex of approximately 1.8 cm subdurally [50].”
MethodInfluentialImpact of Patient Mild Cognitive Impairment on Physician Decision-Making for Treatment
Blair, E. M., Zahuranec, D. B., Langa, K. M., Forman, J. H., Reale, B. K., Kollman, C. D., Giordani, B., & Levine, D. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200700 · Cited by 20
Gellersen, H. M., & Kedzior, K. K. (2018) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000320 · Cited by 13 · cited 1×
“Since the approval of dTMS in 2013 by the US Food and Drug Administration for major depressive disorder [40], this method of intervention has gained popularity for the treatment of diverse psychiatric disorders.”
Background
Research works printed but not linked: 1
- GaynesBNAsherGGartlehnerGHoffmanVGreenJBolandELuxLWeberRPRandolphCBannCCoker-SchwimmerEViswanathanMLohrKNDefinition of treatment-resistant depression in the medicare populationAHRQ Technology Assessments20182022-09-28Rockville (MD)Agency for Healthcare Research and Quality (US)http://www.ncbi.nlm.nih.gov/books/NBK526366/
Cited by
Clinical development and guiding theory of transcranial magnetic stimulation: a literature review
Lin, Z., Cheng, J.-L., Tan, C., Liu, Z., & Han, D. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2581921 · Cited by 5
“In addition, there are many versions of TMS coils for the same class. for example, there are nearly 30 different types of hesed coil, which are designed to reflect different subdural depths, stimulation volumes, and stimulation areas to meet the needs of different diseases [100].”
Palantzas, A., & Anagnostouli, M. (2026) · Sensors · doi:10.3390/s26051738 · Cited by 1
Kievišienė, J. (2026) · Lithuanian University of Health Sciences
Metadata
- Authors
- Di Passa, A.-M., Dabir, M., Fein, A., Khoshroo, S., McIntyre-Wood, C., Marsden, E., MacKillop, E., De Jesus, J., MacKillop, J., & Duarte, D.
- Affiliations
- McMaster University (CA)
- Peter Boris Centre for Addictions Research (CA)
- Corresponding author
- Duarte, Dante
- ORCID
- Venue
- JMIR Research Protocols
- Publisher
- JMIR Publications Inc.
- Published
- 2023-05-26
- Volume
- 12
- Pages
- e45213
- ISSN
- 1929-0748 (ISSN-L)
- PMC
- PMC10257110
- OpenAlex
- W4367336381
- Cited by
- 2
- References
- 64
- Citations by year
- 2026: 1 · 2025: 1
- FWCI
- 0.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Research Protocols (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Medical Research Council
- National Medical Research Council
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- deep transcranial magnetic stimulation, H-coil, mental illness, cognitive disorders, dementia, subgroup analysis, stimulation parameters, motor threshold, non-invasive brain stimulation, clinical efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.